高齢者の認知障害のスクリーニング:米国予防サービスタスクフォースの最新証拠報告と体系的レビュー
Carrie D Patnode1, Leslie A Perdue1, Rebecca C Rossom2
1Kaiser Permanente Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon.
JAMA
|February 26, 2020
まとめ
認知障害の早期スクリーニングは 病状を正確に検知しますが 患者の状態を改善しません 介入は患者や介護者にとって わずかな不確実な利益をもたらし さらなる研究が必要であることを強調しています
科学分野:
- ゲロントロジー
- 神経科学
- 予防 医療
背景:
- 認知障害の早期発見は 高齢者とその介護者の健康状態を改善するために不可欠です
- 認知障害は,軽度の認知障害 (MCI) と認知症を含む,高齢者の大きな部分に影響します.
研究 の 目的:
- 高齢者 (≥65歳) の認知検査器具の精度を体系的に検討する.
- 高齢者の認知障害の治療のための介入の利害を評価する.
- 予防サービス・タスクフォースの勧告を参考にすること.
主な方法:
- MEDLINE,PubMed,PsycINFO,Cochrane 統制試験中央登録書の体系的なレビュー
- MCIや軽度から中等度の認知症のスクリーニング用具と治療法に関する英語での適度から質の高い研究を含める.
- ランダム効果メタ解析と定性合成を用いたデータ抽出と合成
主要な成果:
- 28万人を超える高齢者を対象とした287件の研究が検討されました.
- 認知スクリーニング装置は適切な精度を示した (例えば,ミニメンタルステート試験:感度0.89,特異性0.89).
- スクリーニングでは患者や介護者に対する有意な改善は認められず,介入はわずかな不確実な臨床効果を示した.
結論:
- 認知のスクリーニング装置は 認知障害を効果的に検出します
- 現在の証拠は,スクリーニングが患者や介護者を改善するか,害を防ぐことを支持していません.
- 早期発見された認知障害に対する介入の臨床的意義は不明である.
関連する概念動画
Cognitive Development During Adulthood
694
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
694
Pharmacodynamics in Geriatric Patients: Effects of Age
144
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
144
Drug Dosing: Geriatric Patients
173
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
173
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
456
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
456
Preventive Healthcare Services
1.7K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.7K


